# 119-hr-6485: Skinny Labels, Big Savings Act

119-hr-6485, Skinny Labels, Big Savings Act, is a 119th Congress bill sponsored by Rep. Cline, Ben [R-VA-6] (R-VA); status introduced; PRIA reads it as touching household money (as of 2026-09-21).

- Canonical: https://policyrisk.com/legislation/119-hr-6485
- As of: 2026-09-21
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Bill: 119-hr-6485
- Congress: 119
- Title: Skinny Labels, Big Savings Act
- Status: introduced
- Introduced: 2025-12-05
- Sponsor: Rep. Cline, Ben [R-VA-6] (R-VA)
- Cosponsors: 6
- Policy area: Commerce
- Touches household money: yes
- Last recorded action: 2026-09-21

## Summary

**Creates a patent law safe harbor for certain FDA-regulated generic and biosimilar activities.** This bill would protect specific acts tied to FDA approval and approved labeling from method-of-use patent infringement claims when labeling and promotion do not reference the patented use. - Generic drug applicants and manufacturers would be shielded from infringement claims for submitting or seeking FDA approval, marketing with approved labeling, and describing a product as generic or therapeutically equivalent, as long as the labeling and promotion do not reference the patented condition. - Biosimilar and interchangeable developers would be shielded for seeking approval, describing their product as biosimilar or interchangeable, and marketing with approved labeling when the product is not approved for the patented use and prescribing information does not reflect that use. - Patent holders would face limits on suing for method-of-use claims tied to listed drugs or reference biologics under these conditions, and the protection would apply to conduct and proceedings before, on, or after enactment.

## Cosponsors (6)

- Rep. Lofgren, Zoe [D-CA-18] (D-CA), 2025-12-05T00:00:00.000Z
- Rep. Kiggans, Jennifer A. [R-VA-2] (R-VA), 2026-04-20T00:00:00.000Z
- Rep. Suozzi, Thomas R. [D-NY-3] (D-NY), 2026-04-20T00:00:00.000Z
- Rep. Pfluger, August [R-TX-11] (R-TX), 2026-05-19T00:00:00.000Z
- Rep. Grothman, Glenn [R-WI-6] (R-WI), 2026-06-15T00:00:00.000Z
- Rep. Craig, Angie [D-MN-2] (D-MN), 2026-06-23T00:00:00.000Z

## Provisions PRIA read

- New safe harbor for drug makers: benefit, medium. This bill would protect certain generic, 505(b)(2), animal drug, and biosimilar applicants and sellers from method-of-use patent lawsuits tied to FDA approvals. For generics and similar applicants, it would block infringement claims for filing the required method-of-use statement, selling or promot…

## Related bills

- 119-hr-1262: Mikaela Naylon Give Kids a Chance Act
- 119-hr-3514: Improving Seniors’ Timely Access to Care Act of 2025
- 119-hr-4382: America’s Olympic and Paralympic Games Commemorative Coins Act
- 119-hr-539: Chiropractic Medicare Coverage Modernization Act of 2025
- 119-hr-1227: Alternatives to PAIN Act
- 119-hr-1422: Enhanced Iran Sanctions Act of 2025

## Sources
- [119-hr-6485 on Congress.gov](https://www.congress.gov/bill/119th-congress/house-bill/6485)

## Related
- [119-hr-1262: Mikaela Naylon Give Kids a Chance Act](https://policyrisk.com/legislation/119-hr-1262)
- [119-hr-3514: Improving Seniors’ Timely Access to Care Act of 2025](https://policyrisk.com/legislation/119-hr-3514)
- [119-hr-4382: America’s Olympic and Paralympic Games Commemorative Coins Act](https://policyrisk.com/legislation/119-hr-4382)
- [119-hr-539: Chiropractic Medicare Coverage Modernization Act of 2025](https://policyrisk.com/legislation/119-hr-539)
- [119-hr-1227: Alternatives to PAIN Act](https://policyrisk.com/legislation/119-hr-1227)
- [119-hr-1422: Enhanced Iran Sanctions Act of 2025](https://policyrisk.com/legislation/119-hr-1422)
- [All bills in Congress](https://policyrisk.com/legislation)

Source: PRIA, https://policyrisk.com/legislation/119-hr-6485 (as of 2026-09-21).